Invasive fungal infections in non-neutropenic patients
- PMID: 39432102
- DOI: 10.1007/s00134-024-07683-2
Invasive fungal infections in non-neutropenic patients
Conflict of interest statement
Declarations. Conflicts of interest: LK has received speaking fees and a research scholarship from BioMérieux, and has been employed by Transgene. SN has received speaking fees from MSD, Pfizer, Biomérieux, Shionogi, Fisher and Peykel, Medtronic, Mundi Pharma. SB has no conflict of interest related to this work.
References
-
- Kreitmann L, Helms J, Martin-Loeches I et al (2024) ICU-acquired infections in immunocompromised patients. Intensive Care Med 50:332–349. https://doi.org/10.1007/s00134-023-07295-2 - DOI - PubMed
-
- Tsay SV, Mu Y, Williams S et al (2020) Burden of candidemia in the United States, 2017. Clin Infect Dis 71:e449–e453. https://doi.org/10.1093/cid/ciaa193 - DOI - PubMed
-
- Chow JK, Golan Y, Ruthazer R et al (2008) Factors associated with candidemia caused by non-albicans Candida species versus Candida albicans in the intensive care unit. Clin Infect Dis 46:1206–1213. https://doi.org/10.1086/529435 - DOI - PubMed
-
- Bassetti M, Giacobbe DR, Agvald-Ohman C et al (2024) Invasive fungal diseases in adult patients in Intensive Care Unit (FUNDICU): 2024 consensus definitions from ESGCIP, EFISG, ESICM, ECMM, MSGERC, ISAC, and ISHAM. Intensive Care Med 50:502–515. https://doi.org/10.1007/s00134-024-07341-7 - DOI - PubMed - PMC
-
- Donnelly JP, Chen SC, Kauffman CA et al (2020) Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium. Clin Infect Dis 71:1367–1376. https://doi.org/10.1093/cid/ciz1008 - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources